USPTO serial 87209480
NEEM BIOTECH
Reviewed by CopyMark Law Group
Reg. 5362592Status 710
- Filing date
- Status date
- Registration date
- Dec 26, 2017
- Examiner
- NADELMAN, ANDREA KOYNER
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.
Need help with NEEM BIOTECH?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Blaenau Gwent, GB
Blaenau Gwent, GB
Blaenau Gwent, GB
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Mark D. Swanson
Mark D. Swanson Pauley Erickson & Kottis2800 West Higgins RoadSuite 365Hoffman Estates, IL 60169Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations for the treatment and prevention of infectious diseases; veterinary preparations for the reduction of methanogenesis in ruminants, for use as disinfectants for hooves, for use in promoting well-being of animals in the nature of complementary and medicated animal feed, for the treatment and prevention of foot rot in animals; nutraceutical preparations for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control, and strengthening of immune system; chemical preparations for medical, pharmaceutical and/or veterinary purposes, namely, for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; biological preparation for medical, pharmaceutical and/or veterinary purposes, namely, biological tissue cultures; chemico-pharmaceutical preparations for medical, pharmaceutical and/or veterinary purposes, namely, for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; chemical preparations to treat mildew, wheat blight and/or wheat smut; nutritional supplements; nutraceuticals for use as dietary supplements; food supplements; dietary supplements; health food supplements made from plant extracts; plant extracts for pharmaceutical use; plant extracts for nutraceutical use, namely, for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; plant extracts for dietetic use, namely, plant extracts for use as dietary supplements; plant extracts for medical use; plant extracts for nutritional purposes, namely, for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; acaricides; algicides; alginate dietary supplements for pharmaceutical purposes; amino acids for medical purposes; amino acids for veterinary purposes; enzyme preparations for medical purposes; enzymes preparations for veterinary purposes; anthelmintics; antibiotics; antiparasitic preparations; appetite suppressants for medical purposes; drugs for medical purposes, namely, antibiotics, anti-infectives, anti-helminthic for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; herbal teas for medical purposes; enzymes for medical purposes; fumigation preparations for medical purposes; enzyme dietary supplements; enzymes preparations for pharmaceutical purposes; yeast dietary supplements; yeast for pharmaceutical purposes; dietary fiber for the enhancement of microbiome; bacterial poisons; biocides; by-products of the processing of cereals for dietetic and/or medical purposes; lotions for pharmaceutical purposes for use in promoting general well-being of animals in the nature of medicated lotions for treating dermatological conditions, for the treatment and prevention of diseases in animals, namely, for ulcerating wounds, skin diseases, skin conditions and lesions; lotions for veterinary purposes for topical use on animals to treat skin conditions, skin diseases and lesions; meal for pharmaceutical purposes; sanitary preparations for medical purposes; material for medical dressings; material for stopping teeth, dental wax; medicines for dental purposes; medicines for human, namely, antibiotics, anti-infectives, anti-helminthic for the treatment and prevention of infectious diseases and obesity, fat and cholesterol control, blood sugar control and strengthening of immune system; mouthwashes for medical purposes; porcelain for dental prostheses; disinfectants; preparations for destroying dry rot fungus and/or vermin; fungicides; herbicides; medicinal herbs and herbal infusions; insectrepellents; insecticides; parasiticides; and pesticides; all of the foregoing made in whole or significant part of neem | SECTION 8 - CANCELLED | — |
| 031 | Unprocessed grains; fresh fruits; fresh vegetables; agricultural seeds; natural plants; natural flowers; foodstuffs for animals; unprocessed algae for human and animal consumption; pet food; additive to animal feed not for medical purposes and containing garlic extracts, compounds extracted from garlic and compounds derived from garlic sold as a component in finished animal feed; animal feed not for medical purposes; animal and/or livestock fattening preparations containing garlic extracts, compounds extracted from garlic and compounds derived from garlic; edible chews for animals; by-products of the processing of cereals, for animal consumption; cattle cake containing garlic extracts, compounds extracted from garlic and compounds derived from garlic; cattle food; grains for animal consumption and unprocessed grains for human consumption; wheat germ and wheat yeast for animal consumption; stall food for animals; mash for fattening livestock; and strengthening animal forage in the nature of food for animals; all of the foregoing made in whole or significant part of neem | SECTION 8 - CANCELLED | — |
| 042 | Scientific research services; technological services for scientific research, namely, scientific research, scientific analysis in the field of pharmaceutical, nutraceutical and veterinary sciences, scientific testing in the field of pharmaceutical, nutraceutical and veterinary sciences, interpretation of research results in the nature of scientific research analysis in the field of pharmaceutical, nutraceutical and veterinary sciences, testing of nutraceutical goods to assure compliance with nutraceutical industry standards, analysis of pharmaceutical and nutraceutical goods to assure compliance with nutraceutical industry standards, evaluation of nutraceutical goods to assure compliance with nutraceutical industry standards, quality management advisory services for ensuring quality management, quality evaluation and analysis, quality assurance and quality control in the fields of nutraceutical manufacturing, collection and analysis of data, preparation of scientific research documentation, conducting pre-clinical research, conducting experiments for scientific research purposes, preparation of scientific classification reports, and preparation of technical dossiers for scientific and medical research purposes; technical research in the pharmaceutical, nutraceutical and veterinary fields; scientific laboratory services; bacteriological research; biological research; chemical analysis; chemical research; cosmetics research; chemistry services, namely, research in the field of chemistry; product research and/or development in the bio-pharmaceutical and/or nutraceutical field; biological research in the nature of collection and analysis of data in the bio-pharmaceutical and/or nutraceutical field; biological and bacteriological research in the bio-pharmaceutical and/or nutraceutical field; provision of scientific research information and technical information, namely, experimental information in the field of laboratory research services in the bio-pharmaceutical and/or nutraceutical field; and provision of scientific consultancy services in the bio-pharmaceutical and/or nutraceutical field; all of the foregoing concerning neem | SECTION 8 - CANCELLED | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by NEEM BIOTECH LIMITED
- Other trademarks owned by NEEM BIOTECH LIMITED
- Other trademarks owned by NEEM BIOTECH LIMITED
- Other trademarks in Class 005
- Other trademarks in Class 031
- Other trademarks in Class 042
- Similar marks named NEEM BIOTECH
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Jul 12, 2024 | C8.. | CANCELLED SEC. 8 (6-YR) | — |
| Dec 26, 2022 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Dec 26, 2017 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 10, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 10, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Sep 20, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 7, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 7, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 7, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 6, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 6, 2017 | CEPE | COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION ENTERED | — |
| Sep 5, 2017 | GEAN | NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 5, 2017 | GEAP | EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED | — |
| Sep 5, 2017 | CPEA | EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED | — |
| Aug 22, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Aug 22, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 18, 2017 | ALIE | ASSIGNED TO LIE | — |
| Jul 25, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 6, 2017 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2017 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 6, 2017 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 3, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 31, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 26, 2016 | MDSC | NOTICE OF DESIGN SEARCH CODE E-MAILED | — |
| Oct 25, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Oct 24, 2016 | NWAP | NEW APPLICATION ENTERED | — |